Pharmafile Logo

OPEN Health Appoints Matt D’Auria as Chief Executive Officer to Drive Innovation and Growth

March 31, 2025 |  

OPEN Health Group is pleased to announce the appointment of Matt D’Auria as its new Chief Executive Officer (CEO). Based in the US, Matt brings more than 25 years of experience in medical affairs and scientific commercialization to his new role, where he will focus on refining and deploying an innovation and growth strategy.

- PMLiVE

March 31, 2025, London, UK – OPEN Health Group is pleased to announce the appointment of Matt D’Auria as its new Chief Executive Officer (CEO). Based in the US, Matt brings more than 25 years of experience in medical affairs and scientific commercialization to his new role, where he will focus on refining and deploying an innovation and growth strategy.

Before joining OPEN Health, he served as CEO of the Healthcare Consultancy Group (HCG), a medical communications business within Omnicom. During his tenure, he led enterprise client partnerships, expanded global teams, and developed market access strategies that helped drive consistent growth. Matt has also held agency leadership roles at Envision Communications and Syneos Health, and he cites a diverse set of oncology marketing and sales roles at AstraZeneca for shaping his approach to scientific commercialization.

“I am truly honored to lead OPEN Health at this time,” said Matt. “We have an incredible team, a strong foundation, and an unwavering commitment to providing services that play an important role in the translation of scientific complexity into clinical meaning, bringing medicine closer to patients in need.”

“Matt’s global experience, commitment to scientific excellence, and innovation mindset align perfectly with OPEN Health’s core values and growth strategy,” said Dave King, Chairman of OPEN Health’s Board of Directors. “We are confident that he will lead us to even greater heights, and we are excited for the future under his leadership.”

Matt succeeds Vivid Sehgal, Interim CEO, who will continue his journey with OPEN Health by joining the company’s board as a Non-Executive Director.

 

About OPEN Health
OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient well-being. Working in partnership with our clients, we embrace our different perspectives and strengths to deliver fresh thinking and solutions that make a difference. OPEN Health is a flexible global organization that solves complex healthcare challenges across consulting, HEOR and market accessscientific communicationspatient engagement, and creative omnichannel communications. To learn more, visit www.openhealthgroup.com

 

Contact:

Candice Subero, VP of Global Marketing

Email: candicesubero@openhealthgroup.com

This content was provided by OPEN Health

Company Details

 Latest Content from  OPEN Health 

The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease

The right measurement frameworks matter for demonstrating treatment efficacy in clinical trials for Alzheimer’s Disease

OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

OPEN Health Presenting Innovative Research on Capitalizing Data for Patient Access at ISPOR Europe

Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

Embracing the Patient Voice Within Publications

This whitepaper will explore multidisciplinary perspectives on how we can better engage patient communities in publications to optimize the value of their contributions, while navigating any uncertainties and reluctance from...

Navigating the nocebo effect through patient engagement is the key to setting patients up for success

If you're interested in delving deeper into this topic and understanding how patient engagement can effectively navigate the nocebo effect, we invite you to explore our latest whitepaper.

OPEN Health announces a new team of experts will lead its HEOR & Market Access Scientific Office

OPEN Health, a global provider of consultancy, HEOR and market access, and scientific communications services, announced a new team of experts will lead its HEOR & Market Access Scientific Office.

OPEN Health Appoints Richard Jones as President for Evidence & Access

OPEN Health is pleased to announce the appointment of Richard Jones as President for Evidence & Access.

Drive, Discover, Dive_OPEN Health

Learn how to unlock the power of simplicity in complex omnichannel healthcare communications.

Novel Oncology Therapies Require Innovative Methods in Oncology Modeling

Innovative methods in oncology modeling are needed to demonstrate the value of many new cancer treatments, including immuno-oncologic therapies.

The CM Group rebrands to OPEN Health

Following its acquisition by OPEN Health in 2022, The CM Group, a US healthcare agency offering a suite of solutions to the biotech and pharma industry, has undergone extensive rebranding...